Programs | DEEP Measures

Digital Measures Advocacy Programs

DEEP operates the Global Advocacy Network (GAN) that coordinates external advocacy efforts globally and delivers innovation projects with key authorities to design and implement a global blueprint for digital measure reviews and acceptance.

Nocturnal Scratch Program

Nocturnal scratching significantly impacts the lives of millions suffering from atopic dermatitis and psoriasis. While promising digital solutions may exist, we lack validated measures for clinical trials and patient care. DEEP is spearheading efforts to change this.

We are aiming to create regulatory accepted digital measures for nocturnal scratch. We are building on groundbreaking work by DiMe, the EMA Pilot and Decode.

We're launching two collaborative missions to develop and validate digital measures for nocturnal scratch assessment, focusing on meeting FDA and EMA regulatory requirements.

Development Programs

DEEP methods and tools are used for different digital measures initiatives to execute them end-to-end.

Mobility measures in Parkinson's Disease, extensions to other areas

Cognition measures in neurodegenerative diseases

Respiratory measures in Asthma, COPD, ...

Sleep measures and their application in a range of contexts of use

Seizures in Epilepsy and other conditions

Digital Measures for Motor Speech

Motor speech is a critical endpoint in clinical trials for diseases such as Parkinson’s and related disorders. Digital tools, can provide objective measurements of speech patterns, offering insights into disease progression and treatment efficacy.

DEEP is aiming to create accepted digital measures for speech and voice analysis to improve data collection and processing, streamline clinical trial workflow and enhance drug development programs

We are launching two initiatives (missions) aiming to digitalize and automate measures of speech in Parkinson and related disorders

Launching Soon

Other Programs

Priorities are driven by our members